Choi You-Jung, Park Jun-Bean, Hwang In-Chang, Lee Seung-Pyo, Kim Hyung-Kwan, Kim Yong-Jin, Sohn Dae-Won
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
Int J Cardiovasc Imaging. 2019 Mar;35(3):481-489. doi: 10.1007/s10554-018-1473-3. Epub 2018 Oct 20.
Although proteinuria is a well-known risk factor for cardiovascular disease, its relationship with the progression of aortic stenosis (AS) has not been established. Our aim was to investigate the relationship between proteinuria (detected by urine dipstick test) and AS progression (assessed by the annualized reduction rate of aortic valve area [AVA]). A total of 460 patients with mild to moderate AS (defined by a peak velocity of 2.0-4.0 m/s) without end-stage renal disease who underwent two echocardiograms at least 3 months apart were included. The progression of AS was significantly faster in patients with proteinuria than those without (108 patients vs. 352 patients; annualized reduction rate of AVA, - 7.7 ± 13.5% vs. - 4.5 ± 11.6%; p = 0.017). The relationship between the presence of proteinuria and the accelerated progression of AS was significant among patients with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m (- 11.0 ± 17.5% vs. - 4.2 ± 10.0%; p < 0.001), but not among those with eGFR 15-60 mL/min/1.73 m (- 5.8 ± 10.3 vs. - 5.3 ± 14.8%; p = 0.822). When stratified by the presence of diabetes, the association of proteinuria with AS progression was only significant in patients without diabetes (- 8.1 ± 12.0% vs. - 8.1 ± 15.7%; p = 0.018). Multivariable logistic regression analysis identified that the presence of proteinuria was an independent predictor of AS progression. The progression of AS was accelerated in patients with mild to moderate AS and proteinuria, particularly among those with preserved renal function and no diabetes.
虽然蛋白尿是心血管疾病的一个众所周知的危险因素,但其与主动脉瓣狭窄(AS)进展的关系尚未明确。我们的目的是研究蛋白尿(通过尿试纸条检测)与AS进展(通过主动脉瓣面积[AVA]的年化降低率评估)之间的关系。纳入了460例无终末期肾病的轻至中度AS患者(定义为峰值速度2.0 - 4.0 m/s),这些患者至少间隔3个月接受了两次超声心动图检查。有蛋白尿的患者AS进展明显快于无蛋白尿的患者(108例 vs. 352例;AVA年化降低率,-7.7±13.5% vs. -4.5±11.6%;p = 0.017)。在估计肾小球滤过率(eGFR)≥60 mL/min/1.73 m²的患者中,蛋白尿的存在与AS加速进展之间的关系显著(-11.0±17.5% vs. -4.2±10.0%;p < 0.001),但在eGFR为15 - 60 mL/min/1.73 m²的患者中不显著(-5.8±10.3 vs. -5.3±14.8%;p = 0.822)。按糖尿病的存在进行分层时,蛋白尿与AS进展的关联仅在无糖尿病的患者中显著(-8.1±12.0% vs. -8.1±15.7%;p = 0.018)。多变量逻辑回归分析确定蛋白尿的存在是AS进展的独立预测因素。轻至中度AS且有蛋白尿的患者AS进展加速,特别是在肾功能保留且无糖尿病的患者中。